There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Progyny Inc. (PGNY) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.84, or -2.46%, to $33.26. The Progyny Inc. has recorded 23,606 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Progyny, Inc. to Present at Bank of America Health Care Conference 2023.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
This NASDAQ-listed company operates within the Health Information Services industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $34.10 and fluctuated between $34.70 as its day high and $33.25 as its day low. The current market capitalization of Progyny Inc. is $3.24B. A total of 0.57 million shares were traded on the day, compared to an average of 977.52K shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, PGNY has seen 16 BUY and 48 SELL insider trades, representing the acquisition of 406,864 and the disposition of 458,553 shares. Over the last 12 months, there were 84 BUYs and 304 SELLs from insiders. Insiders purchased 1,970,620 shares during that period but sold 3,079,400.
In the most recent transaction, Payson Norman sold 200 shares of PGNY for 56.29 per share on Nov 23. After the transaction, the Director now owns 580,656 company shares. In a previous transaction on Apr 24, Schlanger David J sold 10,224 shares at 35.00 per share. PGNY shares that Executive Chairman owns now total 73,487.
Among the insiders who sold shares, Anevski Peter disposed of 1,857 shares on Apr 24 at a per-share price of $35.00. This resulted in the CHIEF EXECUTIVE OFFICER holding 215,924 shares of PGNY after the transaction. In another insider transaction, Anevski Peter sold 464 shares at $35.00 per share on Apr 24. Company shares held by the CHIEF EXECUTIVE OFFICER now total 83,483.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for PGNY in the last 3 months, the mean price target is $46.57 with high estimates of $61.00 and low estimates of $34.00. In terms of 52-week highs and lows, PGNY has a high of $46.50 and a low of $25.67.
As of this writing, PGNY has an earnings estimate of $0.07 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $0.08 per share and a lower estimate of $0.06. The company reported an EPS of $0.13 in the last quarter, which was 160.00% higher than expectations of $0.05.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PGNY’s latest balance sheet shows that the firm has $119.42M in Cash & Short Term Investments as of fiscal 2021. There were $7.42M in debt and $98.82M in liabilities at the time. Its Book Value Per Share was $4.05, while its Total Shareholder’s Equity was $251.82M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 7 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PGNY is Overweight with a score of 4.71. A total of 6 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.